Stock Taper
SCREENER COMPARE ANY 2 STOCKS
CDNA
CAREDX, INC
NASDAQ
$49.79
▼ DOWN 4.91% (-2.57)

KEY STATISTICS

Market Cap$2.58 B
52w High$53.67
52w Low$12.37
Dividend Yield—
Frequency—
P/E59.27
Volume1.18M
Shares Out.51.73M

COMPANY

LEADERSHIP

John Walter Hanna Jr.
CHIEF EXECUTIVE
John Walter Hanna Jr.

COMPENSATION 2026

Salary$693,269
Stock Awards$5,622,638
Incentive Plan Pay$852,515
All Other Comp.$11,277
Total$7,179,699

ABOUT

SECTOR
Healthcare
WENT PUBLIC
July 17, 2014
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
763

PRICE TARGET

Target High$64.00
Target Low$46.00
Target Median$60.00
Target Consensus$56.67

UPCOMING EARNINGS

DateNov 3, 2026
DayTuesday
Rev. Est.$121.90M
NOV
3
TUE

PRICE

$49.79 ▼ DOWN 4.91% (−$2.57)
$49.50$50.25$51.00$51.759:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM49.79

About CareDx, Inc

https://www.caredx.com ↗

CareDx, Inc. develops and commercializes diagnostic solutions—including dd-cfDNA, HLA typing, and transplant management tools—for transplant patients worldwide.

INDUSTRY

Medical - Diagnostics & Research

A PRODUCT CAREDX, INC IS KNOWN FOR

AlloHeme
AlloHeme

AlloHeme is an AI-powered, non-invasive test that predicts relapse in AML and MDS patients post-transplant, with validated clinical results, marking CareDx's expansion into cell therapy and oncology.

COMPETITORS

COMPETITOR
BIO COMPARE
ILMN COMPARE
NTRA COMPARE
TMO COMPARE
VCYT COMPARE

Revenue by Products

IconPRODUCTQ3-2025Q4-2025Q1-2026Q2-2026
Service$72.17M $78.37M ▲$91.4M ▲$99.93M ▲
Product$12.48M $13.26M ▲$10.35M ▼$12.79M ▲

Revenue by Geography

MapREGIONQ3-2025Q4-2025Q1-2026Q2-2026
UNITED STATES$95.06M $103.38M ▲$113.65M ▲$126.63M ▲
NonUS— — $4.05M $5.32M ▲
Rest of the World$5M — — —

ETFS HOLDING THIS STOCK

ETFS HOLDING
166
LISTED HERE
26
RANKED BY POSITION SIZE
VTI
0.00% · 1.6M
ARKG
3.82% · 1.6M
IWM
0.08% · 1.3M
XBI
0.54% · 1.2M
PBE
5.48% · 427.3K
SCHA
0.06% · 246.3K
JSMD
1.09% · 231.8K
FESM
0.18% · 231.2K
DFMC
0.12% · 181.5K
DOCG.L
2.84% · 178.9K
AVSC
0.17% · 101.0K
BR
BRES
0.67% · 92.2K
GSSC
0.42% · 87.5K
PSC
0.15% · 81.4K
XRS2.F
0.08% · 46.9K
NUSC
0.16% · 46.4K
LABU
0.36% · 44.3K
HTEC
2.84% · 42.4K
HY
HYP
2.85% · 39.2K
GNOM
1.79% · 32.6K
EES
0.22% · 30.7K
WSCSRI.SW
0.08% · 13.4K
HELX
1.38% · 8.6K
AAUB
0.04% · 7.5K
SEUS
0.02% · 4.2K
RFLR
0.19% · 3.6K

INSTITUTIONAL OWNERSHIP

SHARES OWNED
66.11%
HOLDERS
326
TOP 12 OF 326 · RANKED BY POSITION SIZE
Blackrock Inc.
5.3M sh · $82.1M
Blackrock, Inc.
4.8M sh · $137.22M
Vanguard Group Inc
3.7M sh · $54.52M
Bamco Inc /Ny/
3.3M sh · $57.92M
State Street Corp
2.8M sh · $47.92M
Ark Investment Management LLC
2.2M sh · $38.67M
Ophir Asset Management Pty Ltd
2.2M sh · $31.96M
Deerfield Management Company, L.P. (Series C)
2.2M sh · $31.86M
Braidwell LP
2.2M sh · $31.74M
Boston Partners
1.9M sh · $55.22M
Gagnon Securities LLC
1.8M sh · $33.44M
Sumitomo Mitsui Trust Holdings, Inc.
1.7M sh · $25.3M

RATINGS SNAPSHOT

Overall rating: B+

DCFROEROAD/EP/EP/B
Discounted Cash Flow1
Return On Equity5
Return On Assets5
Debt To Equity4
Price To Earnings2
Price To Book2
Overall Score3

TRADES BY CONGRESS

HOUSE TRADES
Daniel Goldman
Daniel Goldman
Sale (Full)
2023-03-06
 Tom Malinowski
Tom Malinowski
Purchase
2021-12-29

INSIDER TRADES

★
OFFICER: SECRETARY AND GENERAL COUNSEL
Novack Jeffrey Adam
Sale · 2.2K shares
2026-08-05
★
DIRECTOR
Bickerstaff George
Sale · 20.0K shares
2026-08-05
★
DIRECTOR
COURNOYER CHRISTINE
Sale · 16.0K shares
2026-08-04
★
OFFICER: SECRETARY AND GENERAL COUNSEL
Novack Jeffrey Adam
Sale · 500 shares
2026-08-05

MOST RECENT ANALYST GRADES

GRADE SUMMARY
BUY 1
NEUTRAL 1
EQUAL WEIGHT 1
3 GRADES IN THE LAST 12 MONTHS
BTIG BUY HC Wainwright & Co. NEUTRAL Wells Fargo EQUAL WEIGHT

SECTORS PEERS

PEERPRICE
VIR$10.83COMPARE
PSNL$17.07COMPARE
MRVI$7.68COMPARE
CSTL$33.50COMPARE
CRMD$8.30COMPARE
FLGT$19.61COMPARE
EVH$4.60COMPARE
EMBC$5.05COMPARE